פלודרה

Kraj: Izrael

Język: hebrajski

Źródło: Ministry of Health

Składnik aktywny:

FLUDARABINE PHOSPHATE 50 MG/VIAL

Dostępny od:

SANOFI - AVENTIS ISRAEL LTD

Kod ATC:

L01BB05

Forma farmaceutyczna:

POWDER FOR SOLUTION FOR INJ/INF

Droga podania:

I.V

Wyprodukowano przez:

GENZYME EUROPE B.V., NETHERLANDS

Grupa terapeutyczna:

FLUDARABINE

Wskazania:

Palliative treatment of patients with CLL refractory to other therapy. Treatment of less malignant Non-Hodgkin lymphoma of stage 3 to 4 in patients who have not responded to standard therapy with at least one alkylating agent or in whom the disease progressed during or after standard therapy. Fludara is indicated for the initial treatment of patients with B- cell chronic lymphocytic leukaemia (CLL) or after first line therapy, in patients with sufficient bone marrow reserves.

Data autoryzacji:

2009-02-01